Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27516225 | 1.00 | PDE4A (0.58) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL4422883 | 1.00 | PDE4A (0.58) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL321750 | 1.00 | PDE4A (0.58) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| Ammonia Solution, Strong SCHEMBL27782446 | 0.98 | PDE4A (0.56) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| Hydrochloric Acid SCHEMBL27659069 | 0.98 | PDE4A (0.56) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| Methane SCHEMBL28111172 | 0.98 | PDE4A (0.56) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| Bromide SCHEMBL27760150 | 0.98 | PDE4A (0.56) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL6514261 | 0.93 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL26605110 | 0.93 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL626497 | 0.93 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118063535-A | Modified nucleoside containing amino derivative structure, oligonucleotide compound and synthesis method | 北京安龙生物医药有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-116789679-A | Cycloicaritin 5-glycosylation derivative and preparation method and application thereof | 遵义医科大学 | 2023-09-22 | — | — | CN | claimed |
| CN-114085256-A | Beta-galactosidase response carbohydrate derivative and application thereof | 江南大学 | 2022-02-25 | — | — | CN | claimed |
| CN-113416219-A | Glycosyl spiropyran compound and application thereof | 华东理工大学 | 2021-09-21 | — | — | CN | claimed |
| CN-112625075-A | alpha-L-fucosidase detection probe and preparation method and application thereof | 华东理工大学 | 2021-04-09 | — | — | CN | claimed |
| CN-110101684-A | A kind of cellular membrane biomimetic nano particle and its preparation method and application of bio-orthogonal targeting | 深圳先进技术研究院 | 2019-08-09 | — | — | CN | claimed |
| CN-109952107-A | Lin28a activators and uses thereof | ＴＥＳ控股股份有限公司 | 2019-06-28 | — | — | CN | claimed |
| CN-109239372-A | Abo blood group antigen detectability verifies product and its application | 上海市血液中心 | 2019-01-18 | — | — | CN | claimed |
| CN-109072273-A | Method for regulating protein galactosylation profile of recombinant protein by using holo-acetyl galactose | 阿雷斯贸易股份有限公司 | 2018-12-21 | — | — | CN | claimed |
| CN-108822171-A | A kind of anthraquinone and triazole antibiotic nucleoside analog, synthetic method and its preparing the application in antitumor or antiviral drugs | 河南师范大学 | 2018-11-16 | — | — | CN | claimed |
| US-20070129316-A1 | MUSCLE-STRENGTHENING DRUGS AND ANTI-INFLAMMATORY DRUGS | DAICHO KIKAKU INCORPORATED COMPANY (JP) | 2007-06-07 | — | — | US | claimed |
| WO-2004094445-A1 | A MORE STABLE ANALOG OF ISO-PROPYLTHIOGALACTOSIDE FOR INDUCTION OF PROTEIN EXPRESSION | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC (US) | 2004-11-04 | — | — | WO | claimed |
| EP-0956000-A4 | SYNTHESIS OF GLYCOPHOSPHOLIPID AND PEPTIDE-PHOSPHOLIPID CONJUGATES AND USES THEREOF | UNIV EMORY (US) | 2004-06-09 | — | — | EP | claimed |
| US-6071532-A | SYNTHETIC VACCINES; IMMUNOLOGY; MEDICAL DIAGNOSIS | EMORY UNIVERSITY (US) | 2000-06-06 | — | — | US | claimed |
| EP-0956000-A1 | SYNTHESIS OF GLYCOPHOSPHOLIPID AND PEPTIDE-PHOSPHOLIPID CONJUGATES AND USES THEREOF | EMORY UNIVERSITY (US) | 1999-11-17 | — | — | EP | claimed |
| EP-0946581-A1 | THERAPEUTIC COMPOUNDS | Oxford GlycoSciences (UK) Limited (GB) | 1999-10-06 | — | — | EP | claimed |
| WO-1998028318-A1 | THERAPEUTIC COMPOUNDS | OXFORD GLYCOSCIENCES (UK) LIMITED (GB) | 1998-07-02 | — | — | WO | claimed |
| WO-1998016198-A1 | SYNTHESIS OF GLYCOPHOSPHOLIPID AND PEPTIDE-PHOSPHOLIPID CONJUGATES AND USES THEREOF | EMORY UNIVERSITY (US) | 1998-04-23 | — | — | WO | claimed |
| EP-0762884-A1 | MODULATORS OF PNEUMOCOCCAL ADHESION TO CELLULAR TARGETS INVOLVING THE PLATELET ACTIVATING FACTOR RECEPTOR, AND USES THEREOF | THE ROCKEFELLER UNIVERSITY (US) | 1997-03-19 | — | — | EP | claimed |
| WO-1995035112-A2 | MODULATORS OF PNEUMOCOCCAL ADHESION TO CELLULAR TARGETS INVOLVING THE PLATELET ACTIVATING FACTOR RECEPTOR, AND USES THEREOF | THE ROCKEFELLER UNIVERSITY (US) | 1995-12-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129316-A1 | MUSCLE-STRENGTHENING DRUGS AND ANTI-INFLAMMATORY DRUGS | CYP27A1, ACHE, MYLK | PDE4A 3446/4885LMNA 829/4885L3MBTL1 4393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.